Clinical utility of HCV core antigen detection and quantification in the diagnosis and management of patients with chronic hepatitis C receiving an all-oral, interferon-free regimen.

Stephane CHEVALIEZ, J Feld, K Cheng, H Wedemeyer, C Sarrazin, B Maasoumy, C Herman, J Hackett, D Cohen, G Dawson, Jean-Michel PAWLOTSKY, G Cloherty,

Antivir Ther. 26/04/2016;- : - 10.3851/IMP3042 24/07/2017

Nuclear Envelope Protein SUN2 Promotes Cyclophilin-A-Dependent Steps of HIV Replication.

X Lahaye, T Satoh, M Gentili, S Cerboni, A Silvin, C Conrad, Abdelhakim AHMED-BELKACEM, EC Rodriguez, JF Guichou, N Bosquet, M Piel, R Le Grand, MC King, Jean-Michel PAWLOTSKY, N Manel,

Cell Rep. 13/04/2016;15(4) : 879-892 10.1016/j.celrep.2016.03.074 13/04/2016

Cellular Mechanism for Impaired Hepatitis C Virus Clearance by Interferon Associated with IFNL3 Gene Polymorphisms Relates to Intrahepatic Interferon-λ Expression.

P Ferraris, PK Chandra, R Panigrahi, F Aboulnasr, S Chava, R Kurt, Jean-Michel PAWLOTSKY, L Wilkens, P Osterlund, R Hartmann, LA Balart, T Wu, S Dash,

Am J pathol 01/04/2016;186(4) : 938-951 10.1016/j.ajpath.2015.11.027 16/02/2016

Dried Blood Spots: A Tool to Ensure Broad Access to Hepatitis C Screening, Diagnosis, and Treatment Monitoring.

Alexandre SOULIER, Lila POITEAU, I Rosa, Christophe HEZODE, F Roudot-Thoraval, Jean-Michel PAWLOTSKY, Stephane CHEVALIEZ,

J Infect Dis. 01/04/2016;213(7) : 1087-1095 10.1093/infdis/jiv423. 02/09/2015

Virologic Tools for HCV Drug Resistance Testing.

Slim FOURATI, Jean-Michel PAWLOTSKY,

Viruses. 04/12/2015;7(12) : 6346-6359 10.3390/v7122941.

Reply to "Debilitating fatigue as a treatment indication in chronic hepatitis C".

Jean-Michel PAWLOTSKY, A Aghemo, D Back, G Dusheiko, X Forns, M Puoti, C Sarrazin,

J Hepatol. 01/12/2015;63(6) : 1535-1536 10.1016/j.jhep.2015.09.004 12/09/2015

Therapy: Avoiding treatment failures associated with HCV resistance.

Jean-Michel PAWLOTSKY,

Nat Rev Gastroenterol Hepatol. 01/12/2015;12(12) : 673-674 10.1038/nrgastro.2015.184 27/10/2015

Association between IL28B polymorphism, TNFα and biomarkers of insulin resistance in chronic hepatitis C-related insulin resistance.

M Lemoine, Stephane CHEVALIEZ, JP Bastard, L Fartoux, O Chazouilleres, J Capeau, Jean-Michel PAWLOTSKY, L Serfaty,

J Viral Hepat 01/11/2015;22(11) : 890-896 10.1111/jvh.12408. 26/03/2015

Alisporivir plus ribavirin, interferon free or in combination with pegylated interferon, for hepatitis C virus genotype 2 or 3 infection.

Jean-Michel PAWLOTSKY, R Flisiak, SK Sarin, J Rasenack, T Piratvisuth, WL Chuang, CY Peng, GR Foster, S Shah, H Wedemeyer, Christophe HEZODE, W Zhang, KA Wong, B Li, C Avila, NV Naoumov,

Hepatology. 01/10/2015;62(4) : 1013-1023 10.1002/hep.27960. 10/08/2015

Identification of a duplicated V3 domain in NS5A associated with cirrhosis and hepatocellular carcinoma in HCV-1b patients.

H Le Guillou-Guillemette, A Ducancelle, S Bertrais, C Lemaire, A Pivert, P Veillon, E Bouthry, S Alain, V Thibault, F Abravanel, AR Rosenberg, C Henquell, E Andre-Garnier, O Petsaris, S Vallet, JB Bour, Y Baazia, P Trimoulet, P Andre, C Gaudy-Graffin, D Bettinger, S Larrat, A Signori-Schmuck, H Saoudin, B Pozzetto, G Lagathu, S Minjolle-Cha, F Stoll-Keller, Jean-Michel PAWLOTSKY, J Izopet, C Payan, F Lunel-Fabiani,

J Clin Virol. 01/08/2015;69 : 203-209 10.1016/j.jcv.2015.06.096 24/06/2015